Evidence map›Paper›PMID 37310685›Full record

ArticleThe American surgeon2023

Nationwide Outcomes of Pancreaticoduodenectomy for Pancreatic Malignancies: Center Volume Matters.

Carlos Theodore Huerta, Amber L Collier, Alexandra E Hernandez, Cindy Rodriguez, Ankit Shah, Joshua P Kronenfeld, Dido F Franceschi, Danny Sleeman, Alan S Livingstone, Chad M Thorson

Open access · greenAbstract read
In one paragraph

Article in The American surgeon, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
3.2field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Carlos Theodore HuertaDeWitt Daughtry Family Department of Surgery, University of Miami, Miami, FL, USA.
Amber L CollierDeWitt Daughtry Family Department of Surgery, University of Miami, Miami, FL, USA.
Alexandra E HernandezDeWitt Daughtry Family Department of Surgery, University of Miami, Miami, FL, USA.
Cindy RodriguezFlorida State University College of Medicine, Tallahassee, FL, USA.
Ankit ShahUniversity of Miami Miller School of Medicine, Miami, FL, USA.
Joshua P KronenfeldDeWitt Daughtry Family Department of Surgery, University of Miami, Miami, FL, USA.
Dido F FranceschiDeWitt Daughtry Family Department of Surgery, University of Miami, Miami, FL, USA.
Danny SleemanDeWitt Daughtry Family Department of Surgery, University of Miami, Miami, FL, USA.
Alan S LivingstoneDeWitt Daughtry Family Department of Surgery, University of Miami, Miami, FL, USA.
Chad M ThorsonDeWitt Daughtry Family Department of Surgery, University of Miami, Miami, FL, USA.
University of Miami · USFlorida State University · US

Funding

Research Training Program in Surgical OncologyT32CA211034 · NCI · UNIVERSITY OF MIAMI SCHOOL OF MEDICINE · PI MERCHANT, NIPUN B. · 2016 to 2025
$2.7M
NCI NIH HHS T32 CA211034
6 · The paper itself

Abstract

backgroundComplex surgeries such as pancreaticoduodenectomies (PD) have been shown to have better outcomes when performed at high-volume centers (HVCs) compared to low-volume centers (LVCs). Few studies have compared these factors on a national level. The purpose of this study was to analyze nationwide outcomes for patients undergoing PD across hospital centers with different surgical volumes.

methodsThe Nationwide Readmissions Database (2010-2014) was queried for all patients who underwent open PD for pancreatic carcinoma. High-volume centers were defined as hospitals where 20 or more PDs were performed per year. Sociodemographic factors, readmission rates, and perioperative outcomes were compared before and after propensity score-matched analysis (PSMA) for 76 covariates including demographics, hospital factors, comorbidities, and additional diagnoses. Results were weighted for national estimates.

resultsA total of 19,810 patients were identified with age 66 ± 11 years. There were 6,840 (35%) cases performed at LVCs, and 12,970 (65%) at HVCs. Patient comorbidities were greater in the LVC cohort, and more PDs were performed at teaching hospitals in the HVC cohort. These discrepancies were controlled for with PSMA. Length of stay (LOS), mortality, invasive procedures, and perioperative complications were greater in LVCs when compared to HVCs before and after PSMA. Additionally, readmission rates at one year (38% vs 34%, P < .001) and readmission complications were greater in the LVC cohort.

conclusionsPancreaticoduodenectomy is more commonly performed at HVCs, which is associated with less complications and improved outcomes compared to LVCs.

Indexed as

Pancreatic NeoplasmsPancreaticoduodenectomyAgedComorbidityHospitalsHospitals, High-VolumeHumansLength of StayMiddle AgedRetrospective Studiescenter volumehigh-volume hospitallow-volume hospitalpancreaticoduodenectomy

Identifiers

PMID37310685
PMCPMC10883718
OpenAlexW4380422047

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.